Observational studyRevista medica del Instituto Mexicano del Seguro Social2022
[Cardiorespiratory and neuromusculoskeletal symptoms with post-acute COVID-19 in a Rehabilitation center].
Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: COVID-19 predominantly affects the respiratory system. However, persistent extrapulmonary (musculoskeletal and cardiovascular) conditions have been reported. Objective: To determine the most frequent cardiorespiratory and neuromusculoskeletal symptoms in patients with post-acute COVID 19 in a rehabilitation center. Material and methods: An observational, cross-sectional, descriptive and analytical study of post-acute COVID-19 patients was carried out. Clinical-demographic data, cardiorespiratory and neuromusculoskeletal symptoms were collected upon admission to the cardiopulmonary rehabilitation program. Descriptive statistics and association tests were used through the Chi squared test, taking p < 0.05 as significant. Results: 262 files were collected. The age was 49.9 ± 11.5 years. There was a predominance of males (69.8%). The most prevalent symptoms, in the different degrees of severity (mild, moderate, severe and critical, respectively) were MRC 3 dyspnea (30.4%, 56.8%, 43.1% and 42.9%), weakness (60.9%, 59.5%, 56.9 % and 87.8%), and paresthesias (65.2%, 56.8%, 49.7% and 75.5%). SARS-CoV-2 critical infection was associated with a higher presentation of weakness (p < 0.01), paresthesias (p = 0.01), and dependency in activities of daily living (p < 0.01). Conclusions: The most frequent cardiorespiratory and neuromusculoskeletal symptoms in patients with post-acute COVID were dyspnea and paresthesias. Critical infection by SARS-CoV-2 was associated with a greater presentation of weakness, paresthesias and dependence on activities of daily living.
Indexed as
Identifiers
35816638PMC10395979What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.